Dear members,
Coming back from summer and vacation, we feel energized and very encouraged
by many developments in and around the group.
Silicom
Ventures membership has grown over 30% since January of this year and
among the new members are respectful Venture Capitalists and angel investors
with impressive track records.
Following the Netherlands Technology Showcase we have decided to continue
assist other countries to bridge them to the high tech community in
the Silicon Valley. The next showcase will be with Mexico.
More news, after a long wait for the right timing, Silicom Ventures
is proud to announce the launching of its first fund, Silicom Ventures
Fund. The fund will operate in parallel to Silicom forum.
I am looking forward to see you at the Sixth Annual Cocktail party on
October 19th with former secretary of defense William J. Perry and Ballet
San Jose.
Best regards,
Gadi Behar
Exits
Sensant,
a portfolio company of Silicom Ventures was acquired by Siemens
Medical Solutions Ultrasound Division. Sensant developed MEMS based
diagnostic imaging technology for improved 2D and 3D ultrasound imaging.
The company received a bridge loan to while it was looking for additional
funding in parallel with its acquisition negotiations. The deal provided
Silicom Ventures investors 80% ROI on annualized basis (50% over seven
months). For more details on Sensant see the press release http://www.sensant.com/PR/pr_16jun05.htm
New Investments
Nusym
an EDA company developing symbolic simulator for faster chip verification.
The company received $5M from VCs and $500K from angels. Arik Paran
was appointed board observer on behalf of Silicom Ventures investors.
Silicom Ventures Fund
After a
long wait for the right timing we are very proud to announce the launch
of the Silicom Ventures Fund. If you would like more information please
contact [email protected]
The Netherlands Showcase 2005
The Netherlands
Showcase 2005 was held on August 30th at the Computer History Museum.
The event showcased 11 Dutch companies ranging from medical / pharmaceutical
to materials and technologies. The companies obtained good contacts
with local VCs and potential partners and customers. We had over 300
attendees.
The International Angel Summit
On June
29th, 2006 Silicom Ventures will hold an international angel summit
in partnership with international angels forums from across the globe
in Tel Aviv, Israel. Stay
tuned for more information.
Seminars
A Hacker
seminar was held on 9/20 by Sam Gill, a professor of Information Systems
at SF State University. As a preventative measure, Sam presented and
demonstrate various techniques that hackers use to attack web applications
including: SQL injection, cross-site scripting, input tampering, session
hijacking, identity spoofing, and information disclosure.
Under Due Deligence
BioLert
is a Israeli medical electronics startup company focusing on Epilepsy
Alert systems. Shlomo Shaham the CEO presented in the 8/16 event and
generated interest from a few members. A termsheet was drafted and is
available. If you are interested to learn more please email [email protected]
Kontera
a leading online contextual advertising solutions provider, presented
in the June event. So far a few members already invested and others
are in the process. If you are interested to learn more please email
[email protected]
Portfolio Updates
Ponté
Solutions™ (formally E-Z-CAD) a portfolio company of
Silicom Ventures was ranked among the 6 top EDA companies to watch (the
ranking by EE-Times, the premier industry magazine).
Chakshu
Research that raised series A from Silicom members a year
ago at $5.6M pre money completed a $13.8M Series B financing at a $35M
pre money valuation. The lead investor, Leucadia National Corp, a publicly
traded company listed on the NYSE is the lead investor has invested
$10 million. The new valuation represents a six folds increase in stock
price for the series A investors. The company is going through FDA approval
for its revolutionary non-invasive (eye drops) treatment for cataract.
Spectros,
has achieved the following milestones:
1. FDA and CE shipping clearance received in July 2005
2. Economic studies shows a $2,000 benefit of T-Stat® in vascular
surgery
3. Marketing efforts have started, and T-Stat® is shipping at $600,000/annualized
in last 4 months
4. Trials for $500 million market in Colon surgery is in progress in
the Netherlands
5. Trial for cardiovascular surgery market completed, with results prepared
for clinical publication.
6. Second round Series A funding closed.
Previous Presentors
QueueCard
closed Series A financing round
Aerielle®,
Inc. SanDisk® Corporation Licenses Aerielle® Technology
for Sansa™ Digital Music Player FM Transmitter Accessory.
Coastal
Hydrogen Energy, Inc. is moving forward with the construction
of its dedicated prototype for the production of hydrogen from water
using its unique photocatalytic process.
Articles
8 Simple Rules for Dating an Angel by CJ Cornell